Septic shock is one of the most challenging problems in criticalcare medicine. Shock due to sepsis accounts for many of thedeaths in medical and surgical intensive care units.1,2,3,4It is estimated that septic shock results in approximately 215,000deaths per year in the United States, a number similar to thenumber of deaths from acute myocardial infarction. However,the two disorders are not similar with respect to the approachto evaluation and management. Myocardial infarction is easierto diagnose and usually presents with characteristic chest painand electrocardiographic changes. The presentation of septicshock is much more nonspecific . . . [Full Text of this Article]
Source Information
From the Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, and Cooper University Hospital — both in Camden, NJ.
Related Letters:
Vasopressin in Septic Shock
Boyle W. A., Leone M., Dünser M. W., Hasibeder W. R., Wenzel V., Landry D. W., Oliver J. A., Mogyorosi A., Russell J. A., Walley K. R.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:2736-2738, Jun 19, 2008.
Correspondence
This article has been cited by other articles:
Lameire, N., van Biesen, W., Hoste, E., Vanholder, R.
(2009). The prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury. NDT Plus
2: 1-10
[Abstract][Full Text]
Boyle, W. A., Leone, M., Dunser, M. W., Hasibeder, W. R., Wenzel, V., Landry, D. W., Oliver, J. A., Mogyorosi, A., Russell, J. A., Walley, K. R.
(2008). Vasopressin in Septic Shock. NEJM
358: 2736-2738
[Full Text]
Previous
